Another mechanism for enhanced breast cancer cells death may be enhanced intracellular ROS generation due to treatment with ATO combined with inhibition of Flap Endonuclease 1 (FEN1) expression [44]. This evidence concerns the gene FEN1 and breast carcinoma.